| 000 | 01712 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514020948.0 | ||
| 264 | 0 | _c20020131 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0002-9394 | ||
| 024 | 7 |
_a10.1016/s0002-9394(01)01322-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJabs, Douglas A | |
| 245 | 0 | 0 |
_aCharacteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cJan 2002 |
||
| 300 |
_a48-61 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytomegalovirus Retinitis _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 |
_aUveitis _xdiagnosis |
| 700 | 1 | _aVan Natta, Mark L | |
| 700 | 1 | _aKempen, John H | |
| 700 | 1 | _aReed Pavan, Peter | |
| 700 | 1 | _aLim, Jennifer I | |
| 700 | 1 | _aMurphy, Robert L | |
| 700 | 1 | _aHubbard, Larry D | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 133 _gno. 1 _gp. 48-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9394(01)01322-8 _zAvailable from publisher's website |
| 999 |
_c11668099 _d11668099 |
||